LSHTM-CHARITÉ GLOBAL HEALTH LECTURE SERIES

PRETERM BIRTHS IN A COVID19 WORLD: SCIENCE, SYSTEMS AND SOCIAL IMPACT

November 17, 2020 from 16:30-18:00 CET

Location: Online via Zoom

To join, click here: https://bit.ly/pretermbirths PROGRAMME: AMR EVENT PAGE 02

Sixth event into how the current pandemic is MATERNAL, CHILD impacting on families, will explore approaches to mitigating against harm, AND NEWBORN and innovative approaches to reducing HEALTH neonatal mortality.

Programme This sixth event of the LSHTM- Charite Global Health Lecture series Welcome Johanna Hanefeld will focus on preterm births during Opening Anshu Banerjee the COVID-19 pandemic, exploring the Science Keynote Joy Lawn direct and indirect effects of COVID- Panelist 1 Suman Rao 19 on preterm births and care around Panelist 2 Queen Dube the world. During the event, speakers Panelist 3 Silke Mader will share insights Reflections Helga Fogstad

Venue and Audience Contact

This event is open to all and no For queries, please contact: registration is required. Access here: [email protected]. https://bit.ly/pretermbirths.

PAGE 03

MODERATOR

Dr Anshu Banerjee is currently the Director for the Department of Maternal, New born, Child and Adolescent Health and Ageing in the World Health Organization (WHO). He was earlier the Director (Global Coordination) in the Office of the Assistant Director-General in Family, Women’s and Children’s Health, WHO as well as the WHO Country Representative in Albania and Sudan. While based in Geneva with the Reproductive Health and Research (RHR) Geneva, he was seconded to UNMEER in Accra for the Ebola crisis. Dr Banerjee holds a PhD ANSHU in tuberculosis control from the University of Amsterdam, Netherlands, a Master’s in Public Health for Developing BANERJEE Countries from the London School of Hygiene and Tropical Medicine, United Kingdom, and a medical degree from the D I R E C T O R , D E P T O F University of Antwerp, Belgium. M A T E R N A L , N E W B O R N , C H I L D & A D O L E S C E N T H E A L T H A N D A G E I N G

W O R L D H E A L T H O R G A N I Z A T I O N ( W H O )

KEYNOTE SPEAKER

Joy Lawn is Professor of Maternal Reproductive and Child Health and Director of MARCH Centre, London School Hygiene & Tropical Medicine. Joy is an African-born, British-trained paediatrician and perinatal epidemiologist with 30 years’ experience including: clinical care, epidemiological burden estimates, design and evaluation of maternal, newborn and child care services at scale, especially in sub-Saharan Africa. Her paediatric training was in the UK, followed by teaching, implementation and research, mainly living in Africa, JOY LAWN including a decade with Save the Children. Her MPH was from Emory, , USA, whilst at CDC, and her PhD at Institute of P R O F E S S O R O F Child Health, London. She directs the MARCH Centre (Maternal M A T E R N A L Adolescent Reproductive & Child Health) at London School of R E P R O D U C T I V E A N D Hygiene & Tropical Medicine, including more than 600 academics. Her main contribution to global health has been C H I L D H E A L T H developing the evidence-base to measure and reduce the global burden of 2.5 million neonatal deaths, 2.6 million E P I D E M I O L O G Y stillbirths, and 15million preterm births, including informing D I R E C T O R O F M A R C H the relevant Sustainable Development Goal target. She has C E N T E R published >260 peer-reviewed papers including leading several influential Lancet series. She and her research team work on L O N D O N S C H O O L O F large, multi-country studies on newborn health, stillbirths and H Y G I E N E & T R O P I C A L child development worldwide. She is a champion for women’s research leadership, and is one of the few women nominated M E D I C I N E ( L S H T M ) to membership of both UK Academy of Medical Sciences and USA National Academy of Medicine. PAGE 04

PANELIST 1

Dr. Suman Rao is Professor of Neonatology at St. John’s Medical College in Bangalore, South India. She is also a consultant in the Department of Maternal, Newborn, Child, Adolescent and Aging at the WHO. She has worked for over 20 years to improve outcomes of the small and sick newborns and has done pioneering research in Kangaroo mother care and developmentally supportive care in India. She is a national trainer for Neonatal resuscitation and has led the initiatives to mentor Special Newborn Care Units and reduce neonatal mortality. She is keen on low cost innovations and has helped SUMAN RAO to develop low cost remote monitoring of newborns, therapeutic hypothermia devices and CPAP devices. She has P R O F E S S O R been part of WHO projects on immediate KMC, ACTION and Scale up KMC implementation research. She teaches medical D E P A R T M E N T O F and nursing students and supports their budding research N E O N A T O L O G Y interests.

S T . J O H N ' S M E D I C A L C O L L E G E B A N G A L O R E , I N D I A

PANELIST 2

Dr. Queen Dube is Head of at Queen Elizabeth Central Hospital, the largest tertiary hospital in Malawi. Dr. Dube has worked with the Ministry of Health, Saving Newborn Lives, WHO, Pediatrics and Child Health association of Malawi and UNICEF to improve the quality of newborn care in district hospitals and to improve the quality of care for the small and sick newborn in Malawi. She took a leading role in the development of the “Every Newborn Action Plan for Malawi”. She has identified challenges in neonatal care, developed and implemented new technical solutions at various Malawian hospitals. She teaches medical students both undergraduate and postgraduate. She has led several research studies on the QUEEN DUBE small and sick newborn including- neonatal sepsis- Aetiology and long term outcome, Immediate KMC, KMC innovation, H E A D O F P E D I A T R I C S KMC follow up and point of care diagnostics for sick and small newborns. She has also done studies on HIV encephalopathy, Q U E E N E L I Z A B E T H and Emergency paediatric care. Queen is a co-PI on NEST360, C E N T R A L H O S P I T A L , a multi-institutional initiative to halve in patient neonatal M A L A W I mortality in Africa. She is also part of various technical advisory panels for neonatal research trials. PAGE 04 PAGE 04

PANELIST 3

Silke Mader has been a passionate and influential advocate for maternal and newborn health for over 20 years. As a former patient with HELLP syndrome and mother of preterm babies at week 25 (twin boy survived at 515 grams, twin girl deceased), she built on all of her personal experience to improve care for parents, preterm babies and sick newborns. Care that hardly existed at the time. She knows from her own experience that a strong partnership between health professionals and parents is the best way to face the emotional roller coaster ride of a preterm or sick baby and to overcome the obstacles. This led SILKE MADER to establishing EFCNI – European Foundation for the Care of Newborn Infants in Munich 2008 where she acts as C H A I R W O M A N O F T H E Chairwoman and founding member. One of the major E X E C U T I V E B O A R D A N D achievements of the foundation was the establishment of C O - F O U N D E R World Prematurity Day, the development as well as the implementation of The European Standards of Care for Newborn Health founding of the Global Alliance for Newborn E U R O P E A N Care (GLANCE). In times of the pandemic, GLANCE joined F O U N D A T I O N F O R T H E forces with partnering parent organisations, healthcare C A R E O F N E W B O R N professionals and medical societies all over the world to I N F A N T S ( E F C N I ) & develop its first global campaign “Zero Separation. Together for G L O B A L A L L I A N C E O F better care! Keep preterm and sick babies close to their N E W B O R N C A R E parents”. Silke Mader is author and editor of many publications ( G L A N C E ) on topics related to maternal and newborn health and received several national and international awards and medals for her engagement.

REFLECTIONS

Ms. Fogstad comes with a wealth of experience in RMNCAH- related issues. She has 30 years of working experience in public health and has worked many years in developing countries at sub-national and national levels, as well as at international level within multilateral and bilateral agencies. She has also lived and worked many years in Africa. She is a health economist and has co-authored several publications related to public health. Helga has been central in providing technical guidance on Norway’s health, education, research and development portfolio, both through the bilateral programs, as HELGA well as global initiatives and funds supported by Norway. She has also chaired several global processes aimed at forging FOGSTAD consensus and increasing global mobilization for RMNCAH, including chairing and overseeing the development of the first E X E C U T I V E D I R E C T O R UN Secretary General’s Global Strategy for Women’s and Children’s Health, as well as chaired the Policy Coordinating Committee of the Special Research Program on Human P A R T N E R S H I P F O R Reproductive Health (HRP). Ms. Fogstad was the Director of the M A T E R N A L , N E W B O R N Department of Global Health, Education and Research at the A N D C H I L D H E A L T H Norwegian Agency for Development Cooperation, a post she ( P M N C H ) held since 2014.She has extensive experience in forging partnerships and consensus building, and has been a member of numerous Boards and Committees. PAGE 05

Acknowledgements

The lecture series is supported by the Bill & Melinda Gates Foundation, and this lecture is delivered in partnership with European Foundation for the Care of Newborn Infants (EFCNI), the Global Alliance for Newborn Care (GLANCE), NEST360, the Partnership for Maternal, Newborn and Child Health (PMNCH), the World Health Organization and the Healthy Newborn Network (HNN).